|
Health economics
Citations 1731-1740 of 3736 total displayed.
|
Past content
(since Apr 1855):
|
-
- Letters
- Adjuvant trastuzumab for breast cancer: An increasingly common ethical and economic conundrum
- Matthew L Grove
-
BMJ 2005;331:1202, doi: 10.1136/bmj.331.7526.1202-b, (Published 19 November 2005)
-
[Extract]
[Full text]
-
- Letters
- Adjuvant trastuzumab for breast cancer: Editorial does not mention health economics of drug
- E Hamish McLaren
-
BMJ 2005;331:1203, doi: 10.1136/bmj.331.7526.1203, (Published 19 November 2005)
-
[Extract]
[Full text]
-
- Letters
- Data are still needed for HPV immunisation programme
- O Noel Gill and Catherine M Lowndes
-
BMJ 2005;331:1204, doi: 10.1136/bmj.331.7526.1204-b, (Published 19 November 2005)
-
[Extract]
[Full text]
-
- Editor's choice
- Nervous laughter
- Fiona Godlee
-
BMJ 2005;331:, doi: 10.1136/bmj.331.7525.0-f, (Published 12 November 2005)
-
[Extract]
[Full text]
[PDF]
-
- Editorials
- Diabetes and the quality and outcomes framework
- Colin Kenny
-
BMJ 2005;331:1097, doi: 10.1136/bmj.331.7525.1097, (Published 12 November 2005)
-
[Extract]
[Full text]
[PDF]
-
- News roundup
- US panel recommends young children receive hepatitis A vaccination
- Fred Charatan
-
BMJ 2005;331:1102, doi: 10.1136/bmj.331.7525.1102-c, (Published 12 November 2005)
-
[Extract]
[Abridged PDF]
[Full text]
-
- Papers
- Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries
- Taghreed Adam, Stephen S Lim, Sumi Mehta, Zulfiqar A Bhutta, Helga Fogstad, Matthews Mathai, Jelka Zupan, and Gary L Darmstadt
-
BMJ 2005;331:1107, doi: 10.1136/bmj.331.7525.1107, (Published 12 November 2005)
- [Abstract]
[Abridged PDF]
[Full text]
[PDF]
-
- Education and debate
- Methods to assess the costs and health effects of interventions for improving health in developing countries
- David B Evans, Tessa Tan-Torres Edejer, Taghreed Adam, Stephen S Lim for the WHO Choosing Interventions that are Cost Effective (CHOICE) Millennium Development Goals Team
-
BMJ 2005;331:1137, doi: 10.1136/bmj.331.7525.1137, (Published 12 November 2005)
-
[Extract]
[Full text]
[PDF]
-
- Letters
- Orphan drugs and the NHS: Fairness in health care entails more than cost effectiveness
- Mark Sheehan
-
BMJ 2005;331:1144, doi: 10.1136/bmj.331.7525.1144-c, (Published 12 November 2005)
-
[Extract]
[Full text]
-
- Letters
- Orphan drugs and the NHS: Consider whom drug regulation is designed to protect
- Tom Marshall
-
BMJ 2005;331:1144, doi: 10.1136/bmj.331.7525.1144-b, (Published 12 November 2005)
-
[Extract]
[Full text]
|
